Form 4 for GOSS Gossamer Bio, Inc.
Accepted 2023-07-26 00:00:00 ET · period of report 2023-07-24 · accession 0001728117-23-000100 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-07-26 | 2023-07-24 | GOSS | Giraudo Bryan | COO, CFO | A - Grant | $1.82 | +54.0K | 180.0K | +43% | +$98.3K |
| DI | 2023-07-26 | 2023-07-24 | GOSS | Giraudo Bryan | COO, CFO | A - Grant | $0.13 | +13.5K | 13.5K | New | +$1,756 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-24 | A | A | 54,020 | $1.82 | 180,010 | I By family trust | — | — | |
| 2 | Derivative | Common Stock | 2023-07-24 | A | A | 13,505 | $0.13 | 13,505 | I By family trust | $2.04 · 2023-07-24 to 2028-07-24 | 13,505 Common Stock Purchase Warrants |